The impact of age and intrauterine contraception on the clinical course of pelvic inflammatory disease

Gynecologic and Obstetric Investigation

Volumn 61, Issue 2, 2006, Pages 65-71

  Viberga, I ^a,b,d   Odlind, V ^b   Berglund, L ^c  

^a RIGA STRADINS UNIVERSITY   (Latvia)

^b UPPSALA UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d NONE   (Latvia)

Author keywords

Intrauterine device; Pelvic inflammatory disease; Surgery

Indexed keywords

ABDOMINAL PAIN; ACTINOMYCES; ADNEXA DISEASE; ADULT; AGE; ANAEROBIC BACTERIUM; ARTICLE; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FEVER; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MEDICAL EXAMINATION; MICROBIOLOGICAL EXAMINATION; PELVIC INFLAMMATORY DISEASE; PERITONEAL DISEASE; PREDICTOR VARIABLE; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURGICAL RISK; TREATMENT FAILURE;

ADULT; AGE FACTORS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTRAUTERINE DEVICES; MIDDLE AGED; PELVIC INFLAMMATORY DISEASE; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 33344458597     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088751     Document Type: Article

References (30)

1. Tailor ES, McMillan JH, Greer BE, Droegemueller W, Thompson HE: The intrauterine device and tubo-ovarian abscess. Am J Obstet Gynecol 1975;123:338-348.
2. Golde SH, Israel R, Ledger WJ: Unilateral tubo-ovarian abscess: a distinct entity. Am J Obstet Gynecol 1977;127:807-810.
3. Manara LR: Management of tubo-ovarian abscess. J Am Osteopath Assoc 1981;81:476-480.
4. Ginsburg DS, Stern JL, Hamod KA, Genardy R, Spence MR: Tubo-ovarian abscess: a retrospective review. Am J Obstet Gynecol 1980;138:1055-1058.
5. Edelman DA, Berger GS: Contraceptive practice and tubo-ovarian abscess. Am J Obstet Gynecol 1980;138:541-544.
6. Viberga I, Odlind V, Berglund L: 'Older' age is a risk factor for pelvic inflammatory disease in IUD users. Acta Obstet Gynecol Scand 2005; in press.
7. Viberga I, Odlind V, Lazdane G, Kroica J, Berglund L, Olofsson S: Microbiology profile in women with pelvic inflammatory disease in relation to IUD use. Infect Dis Obstet Gynecol 2005; in press.
8. Teisala K, Heinonen PK: C-reactive protein in assessing antimicrobial treatment of acute pelvic inflammatory disease. J Reprod Med 1990;35:955-958.
9. Reljic M, Gorisek B: C-reactive protein and the treatment of pelvic inflammatory disease. Int J Obstet Gynecol 1998;60:143-150.
10. Reljic M, But I: Monitoring parameters in the management of patients with tubo-ovarian complexes. Int J Obstet Gynecol 1999;64:273-279.
11. Kirshon B, Faro S, Phillips LE, Pruett K: Correlation of ultrasonography and bacteriology of the endocervix and posterior cul-de-sac of patients with severe pelvic inflammatory disease. Sex Transm Dis 1988;15:103-107.
12. Heinonen PK, Miettinen A: Laparoscopic study on the microbiology and severity of acute pelvic inflammatory disease. Eur J Obstet Gynecol Reprod Biol 1994;57:85-89.
13. Dan M, Samra Z, Katz A, Debby A, Gutman R, Zakut H: Etiology of acute pelvic inflammatory disease proven by laparoscopy. Sex Transm Dis 1993;20:158-163.
14. Lippes J: Pelvic actinomycosis: a review and preliminary look at prevalence. Am J Obstet Gynecol 1999;180:265-269.
15. Halperin R, Levinson O, Yaron M, Bukovsky I, Schneider D: Tubo-ovarian abscess in older women: is the woman's age a risk factor for failed response to conservative treatment? Gynecol Obstet Invest 2003;55:211-215.
16. Jamieson D, Duerr A, Macasaet MA, Peterson HB, Hillis SD: Risk factors for a complicated clinical course among women hospitalized with pelvic inflammatory disease. Infect Dis Obstet Gynecol 2000;8:88-93.
17. Olowokure B, Hawker JI, Harcourt S, Warburton F, Weinberg J, Wilson RC: Influence of material deprivation on hospital admission for gynecologic infections. Eur J Clin Microbiol Infect Dis 2004;23:535-538.
18. Sorbye IK, Jerve F, Staff AC: Reduction in hospitalized women with pelvic inflammatory disease in Oslo over the past decade. Acta Obstet Gynecol Scand 2005;84:290-296.
19. Stadel BV, Schlesselman S: Extent of surgery for pelvic inflammatory disease in relation to duration of intrauterine device use. Obstet Gynecol 1984;63:171-177.
20. Kjar A, Laursen K, Thormann L, Borggaard O, Lebech PE: Copper release from copper intrauterine devices removed after up to 8 years of use. Contraception 1993;47:349-358.
21. Bastidas JM, Cano E, Mora N: Copper corrosion - simulated uterine solutions. Contraception 2000;61:395-399.
22. Beltran-Garcia MJ, Espinosa A, Herreta N, Perez-Zapata AJ, Beltran-Garcia C, Ogura T: Formation of copper oxychloride and reactive oxygen species as cause of uterine injury during copper oxidation of Cu-IUD. Contraception 2000;61:99-103.
23. Anjalika, Gupta I, Gupta SK, Ganguly NK: Reactive oxygen intermediates and reactive nitrogen intermediates in copper intrauterine device users. Contraception 1999;59:67-70.
24. Amla S, Gupta I, Kausalya S, Ganguly NK: Active oxygen species in copper intrauterine device users. Contraception 1993;48:150-156.
25. Pradhan M, Gupta I, Ganguli NK: Nitrites and L-Citrulline levels in copper intrauterine device users. Contraception 1997;55:315-318.
26. Patai K, Berenyi M, Sipos M, Nozal B: Characterization of calcified deposits on contraceptive intrauterine devices. Contraception 1998;58:305-308.
27. Berthou J, Chretien FC, Driguez PA: Degradation of copper IUDs in utero. The process of metallic corrosion. A scanning electron microscope study (in French). Gynecol Obstet Fertil 2003;31:29-42.
28. Berthou J, Chretien FC, Driguez PA: I.U.D. degradation in utero as a function of time: the phenomena of calcification. Radiocrystallographic and scanning electron microscopy study (in French). Gynecol Obstet Fertil 2002;30:22-35.
29. Hick DA: What is risk of infection with IUD use? Lancet 1998;351:1222-1223.
30. Shelton JD: Risk of clinical pelvic inflammatory disease attributable to an intrauterine device. Lancet 2001;357:443.